Parkside Financial Bank & Trust’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$97K Buy
1,545
+45
+3% +$3.13K 0.01% 694
2025
Q4
$99.6K Sell
1,500
-123
-8% -$7.95K 0.01% 696
2025
Q3
$109K Sell
1,623
-236
-13% -$18.7K 0.01% 637
2025
Q2
$162K Sell
1,859
-187
-9% -$14.7K 0.02% 484
2025
Q1
$140K Buy
2,046
+37
+2% +$3.02K 0.02% 470
2024
Q4
$156K Buy
2,009
+325
+19% +$24.1K 0.02% 442
2024
Q3
$113K Sell
1,684
-622
-27% -$51.1K 0.02% 513
2024
Q2
$261K Buy
2,306
+12
+0.5% +$1.52K 0.04% 296
2024
Q1
$318K Buy
2,294
+208
+10% +$26.1K 0.05% 267
2023
Q4
$259K Buy
2,086
+218
+12% +$22.3K 0.05% 263
2023
Q3
$174K Hold
1,868
0.04% 287
2023
Q2
$240K Buy
1,868
+103
+6% +$12.5K 0.06% 230
2023
Q1
$205K Buy
1,765
+7
+0.4% +$784 0.06% 232
2022
Q4
$199K Buy
1,758
+286
+19% +$31.4K 0.06% 227
2022
Q3
$119K Sell
1,472
-69
-4% -$5.84K 0.04% 301
2022
Q2
$114K Buy
1,541
+961
+166% +$87.7K 0.03% 305
2022
Q1
$74K Buy
580
+16
+3% +$1.75K 0.02% 420
2021
Q4
$75K Buy
564
+120
+27% +$17.2K 0.02% 422
2021
Q3
$61K Buy
444
+184
+71% +$23.2K 0.02% 448
2021
Q2
$28K Buy
260
+152
+141% +$14.6K 0.01% 670
2021
Q1
$10K Buy
108
+36
+50% +$3.38K ﹤0.01% 925
2020
Q4
$6K Sell
72
-332
-82% -$29.6K ﹤0.01% 1030
2020
Q3
$42K Buy
404
+4
+1% +$418 0.01% 446
2020
Q2
$41K Sell
400
-152
-28% -$13.6K 0.01% 465
2020
Q1
$37K Sell
552
-220
-28% -$13.7K 0.01% 424
2019
Q4
$42K Buy
772
+76
+11% +$3.6K 0.01% 467
2019
Q3
$26K Buy
696
+64
+10% +$2.49K 0.01% 549
2019
Q2
$24K Hold
632
0.01% 579
2019
Q1
$19K Sell
632
-64
-9% -$2.25K 0.01% 619
2018
Q4
$21K Buy
696
+64
+10% +$2.03K 0.01% 551
2018
Q3
$23K Hold
632
0.01% 564
2018
Q2
$15K Buy
632
+368
+139% +$7.8K 0.01% 656
2018
Q1
$5K Buy
+264
New +$3.9K ﹤0.01% 843
2017
Q3
Sell
-568
Closed -$10K 1412
2017
Q2
$10K Sell
568
-264
-32% -$4.88K ﹤0.01% 736
2017
Q1
$18K Buy
832
+232
+39% +$4.53K 0.01% 556
2016
Q4
$9K Sell
600
-192
-24% -$3.4K ﹤0.01% 723
2016
Q3
$17K Sell
792
-56
-7% -$1.25K 0.01% 602
2016
Q2
$17K Buy
848
+160
+23% +$2.72K 0.01% 572
2016
Q1
$12K Buy
688
+260
+61% +$4.34K 0.01% 620
2015
Q4
$9K Buy
428
+276
+182% +$5.74K ﹤0.01% 672
2015
Q3
$3K Buy
+152
New +$3.39K ﹤0.01% 843

Other funds holding DXCM

Parkside Financial Bank & Trust's DXCM Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its DexCom (DXCM) stake by 3% in Q1 2026, buying an estimated $3.13K and bringing the position to 1,545 shares worth $97K. The position accounts for 0.01% of the portfolio, ranked #694.

Parkside Financial Bank & Trust first reported a position in DXCM in Q3 2015 and has held it in 41 quarters since. The position peaked at $318K in Q1 2024. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Parkside Financial Bank & Trust held 1,545 shares of DexCom worth $97K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 45 DexCom shares in Q1 2026, an estimated $3.13K.
  • DexCom made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #694 holding.
  • Parkside Financial Bank & Trust first reported a position in DexCom in Q3 2015 and has held it in 41 quarters since.
  • Parkside Financial Bank & Trust's DexCom position peaked at $318K in Q1 2024.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.